Estradiol Ameliorates Acute Kidney Ischemia-Reperfusion Injury by Inhibiting the TGF-βRI-SMAD Pathway.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2022
Historique:
received: 26 11 2021
accepted: 17 01 2022
entrez: 14 3 2022
pubmed: 15 3 2022
medline: 3 5 2022
Statut: epublish

Résumé

Renal ischemia-reperfusion injury (IRI) is less extensive in females than males in both animals and humans; however, this protection diminishes after menopause, suggesting that estrogen plays a pivotal role in IRI, but the underlying mechanism remains largely unknown. Our study found that 45 min of warm ischemia was sufficient to induce significant pathological changes without causing death in model animals. Compared with male rats, female rats exhibited less extensive apoptosis, kidney injury, and fibrosis; these effects were worsened in ovariectomized (OVX) rats and ameliorated upon estradiol (E

Identifiants

pubmed: 35281024
doi: 10.3389/fimmu.2022.822604
pmc: PMC8907449
doi:

Substances chimiques

Estrogen Receptor alpha 0
Estradiol 4TI98Z838E

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

822604

Informations de copyright

Copyright © 2022 Ren, Li, Di, Xiong, Zhang, Ma, Bian, Lang, Ye and Wang.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The handling editor NG declared a past coauthorship with one of the authors YW.

Références

Chin Med J (Engl). 2018 Nov 5;131(21):2558-2565
pubmed: 30381589
Braz J Med Biol Res. 2021 Jan 25;54(3):e9206
pubmed: 33503202
Ann Surg. 2020 Dec;272(6):1070-1079
pubmed: 30614877
Heliyon. 2020 Mar 07;6(3):e03557
pubmed: 32181408
J Am Soc Nephrol. 2012 Dec;23(12):2001-11
pubmed: 23160515
Gen Comp Endocrinol. 2021 Aug 1;309:113792
pubmed: 33872603
J Inflamm (Lond). 2011 Jun 09;8:14
pubmed: 21658244
BMC Nephrol. 2018 Jun 8;19(1):131
pubmed: 29884141
J Biol Chem. 2010 May 7;285(19):14747-55
pubmed: 20207742
J Mammary Gland Biol Neoplasia. 2011 Jun;16(2):109-15
pubmed: 21390570
Lancet. 2015 May 16;385(9981):1975-82
pubmed: 25777665
Shock. 2016 Aug;46(2):158-63
pubmed: 26849629
Eur J Pharmacol. 2012 May 15;683(1-3):270-5
pubmed: 22426161
Front Endocrinol (Lausanne). 2021 Apr 01;12:627903
pubmed: 33868168
FASEB J. 2021 Jul;35(7):e21725
pubmed: 34110636
J Vis Exp. 2013 Aug 09;(78):
pubmed: 23963468
J Am Soc Nephrol. 2013 Apr;24(5):787-99
pubmed: 23539761
Ren Fail. 2012;34(10):1324-32
pubmed: 23030045
Nat Rev Nephrol. 2016 Jun;12(6):325-38
pubmed: 27108839
Mediators Inflamm. 2016;2016:8319283
pubmed: 27610006
J Am Soc Nephrol. 2008 Dec;19(12):2375-83
pubmed: 18815245
J Menopausal Med. 2018 Aug;24(2):75-80
pubmed: 30202755
Br J Surg. 1998 Dec;85(12):1669-73
pubmed: 9876072
Cell Signal. 2018 Dec;52:112-120
pubmed: 30184463
J Clin Med. 2020 Jan 17;9(1):
pubmed: 31963521
Int J Mol Sci. 2021 Jan 07;22(2):
pubmed: 33430254
Theranostics. 2019 Oct 21;9(26):8277-8293
pubmed: 31754396
J Mol Endocrinol. 2015 Jun;54(3):339-49
pubmed: 26069273
J Clin Invest. 2016 May 2;126(5):1643-5
pubmed: 27088804
Adv Drug Deliv Rev. 2021 Oct;177:113911
pubmed: 34358538
Med Res Arch. 2019 Feb 18;7(2):
pubmed: 31276028
Rom J Intern Med. 2012 Apr-Jun;50(2):135-44
pubmed: 23326957
Front Physiol. 2020 Sep 04;11:1093
pubmed: 33013464
Gend Med. 2008;5 Suppl A:S11-8
pubmed: 18395676
Mayo Clin Proc. 2020 Mar;95(3):587-599
pubmed: 32138885
PLoS Genet. 2020 May 19;16(5):e1008796
pubmed: 32428001
Am J Health Syst Pharm. 2019 Aug 1;76(16):1211-1217
pubmed: 31369116
Cells. 2019 Sep 21;8(10):
pubmed: 31546660
J Steroid Biochem Mol Biol. 2018 Sep;182:127-136
pubmed: 29709634
J Clin Invest. 2016 May 2;126(5):1968-77
pubmed: 27088798
Surg Endosc. 2021 Jun 11;:
pubmed: 34115217
Mol Cell Biochem. 2019 Mar;453(1-2):1-9
pubmed: 30194582
ESC Heart Fail. 2019 Aug;6(4):874-877
pubmed: 31271517
Life Sci. 2018 May 15;201:9-16
pubmed: 29567078
Eur Respir J. 2008 Jun;31(6):1183-8
pubmed: 18321929
Nephrol Dial Transplant. 2003 Jan;18(1):54-61
pubmed: 12480960
J Am Soc Nephrol. 2021 Sep;32(9):2117-2124
pubmed: 34108233
J Diabetes Res. 2016;2016:8738760
pubmed: 27446963
Transl Res. 2021 Sep;235:15-31
pubmed: 33789208
Life Sci. 2019 Dec 15;239:117082
pubmed: 31756345
Sci Rep. 2019 Mar 18;9(1):4777
pubmed: 30886220
Int Urol Nephrol. 2021 Nov;53(11):2299-2310
pubmed: 33458788
Int J Clin Exp Pathol. 2020 Sep 01;13(9):2319-2325
pubmed: 33042337
Cell Rep. 2018 Aug 7;24(6):1434-1444.e7
pubmed: 30089255
Neuroendocrinology. 2002 Jul;76(1):1-7
pubmed: 12097811
J Steroid Biochem Mol Biol. 2019 Jul;191:105380
pubmed: 31078693
Am J Physiol Regul Integr Comp Physiol. 2007 Feb;292(2):R794-9
pubmed: 16990489

Auteurs

Lian Ren (L)

Zhongnan Hospital of Wuhan University, Institute of Hepatobiliary Diseases of Wuhan University, Transplant Center of Wuhan University, Hubei Key Laboratory of Medical Technology on Transplantation, Wuhan, China.
Department of General Surgery, Taihe Hospital, Hubei University of Medicine, Shiyan, China.

Fang Li (F)

Eye Center, Renmin Hospital of Wuhan University, Wuhan, China.

Ziyang Di (Z)

Department of Gastrointestinal Surgery & Department of Gastric and Colorectal Surgical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.

Yan Xiong (Y)

Zhongnan Hospital of Wuhan University, Institute of Hepatobiliary Diseases of Wuhan University, Transplant Center of Wuhan University, Hubei Key Laboratory of Medical Technology on Transplantation, Wuhan, China.

Shichen Zhang (S)

Zhongnan Hospital of Wuhan University, Institute of Hepatobiliary Diseases of Wuhan University, Transplant Center of Wuhan University, Hubei Key Laboratory of Medical Technology on Transplantation, Wuhan, China.

Qing Ma (Q)

Zhongnan Hospital of Wuhan University, Institute of Hepatobiliary Diseases of Wuhan University, Transplant Center of Wuhan University, Hubei Key Laboratory of Medical Technology on Transplantation, Wuhan, China.

Xiaoen Bian (X)

Zhongnan Hospital of Wuhan University, Institute of Hepatobiliary Diseases of Wuhan University, Transplant Center of Wuhan University, Hubei Key Laboratory of Medical Technology on Transplantation, Wuhan, China.

Zhiquan Lang (Z)

Zhongnan Hospital of Wuhan University, Institute of Hepatobiliary Diseases of Wuhan University, Transplant Center of Wuhan University, Hubei Key Laboratory of Medical Technology on Transplantation, Wuhan, China.

Qifa Ye (Q)

Zhongnan Hospital of Wuhan University, Institute of Hepatobiliary Diseases of Wuhan University, Transplant Center of Wuhan University, Hubei Key Laboratory of Medical Technology on Transplantation, Wuhan, China.

Yanfeng Wang (Y)

Zhongnan Hospital of Wuhan University, Institute of Hepatobiliary Diseases of Wuhan University, Transplant Center of Wuhan University, Hubei Key Laboratory of Medical Technology on Transplantation, Wuhan, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH